+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Cancer incidence in atomic bomb survivors. Part I: Use of the tumor registries in Hiroshima and Nagasaki for incidence studies



Cancer incidence in atomic bomb survivors. Part I: Use of the tumor registries in Hiroshima and Nagasaki for incidence studies



Radiation Research 137(2 Suppl.): S1-16



More than 30 years ago, population-based tumor registries were established in Hiroshima and Nagasaki. This report, the first of a series of papers on cancer incidence, describes methodological aspects of the tumor registries and discusses issues of data quality in the context of the Life Span Study (LSS) cohort, the major atomic bomb survivor population. The tumor registries in Hiroshima and Nagasaki are characterized by active case ascertainment based on abstraction of medical records at area hospitals, augmented by tissue registries operational in the area and a number of clinical and pathological programs undertaken over the years among the atomic bomb survivors. Using conventional measures of quality, the Hiroshima and Nagasaki tumor registries have a death certificate-only (DCO) rate of less than 9%, a mortality/incidence (M/I) ratio of about 50%, and a histological verification (HV) rate in excess of 70%, which place these registries among the best in Japan and comparable to many established registries worldwide. All tumor registry data pertaining to the LSS population were assembled, reviewed and handled with special attention given to the quality and uniformity of data based on standardized procedures. Special studies and monitoring programs were also introduced to evaluate the quality of the tumor incidence data in the LSS. Analyses were performed to examine the quality of incidence data overall and across various substrata used for risk assessment such as age, time and radiation dose groups. No significant associations were found between radiation dose and data quality as measured by various indices. These findings warrant the use of the present tumor registry-based data for studies of cancer incidence in the atomic bomb survivors.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 008260314

Download citation: RISBibTeXText

PMID: 8127951


Related references

Supplement: Cancer Incidence in Atomic Bomb Survivors. Radiation Effects Research Foundation, Hiroshima and Nagasaki, Japan || Cancer Incidence in Atomic Bomb Survivors. Part I: Use of the Tumor Registries in Hiroshima and Nagasaki for Incidence Studies. Radiation Research 137(2): S1-S16, 1994

A review of forty-five years study of Hiroshima and Nagasaki atomic bomb survivors. Tumor registries and cancer incidence studies. Journal of Radiation Research 32 Suppl: 239-244, 1991

Supplement: Cancer Incidence in Atomic Bomb Survivors. Radiation Effects Research Foundation, Hiroshima and Nagasaki, Japan || Cancer Incidence in Atomic Bomb Survivors. Part IV: Comparison of Cancer Incidence and Mortality. Radiation Research 137(2): S98-S112, 1994

Supplement: Cancer Incidence in Atomic Bomb Survivors. Radiation Effects Research Foundation, Hiroshima and Nagasaki, Japan || Cancer Incidence in Atomic Bomb Survivors. Part II: Solid Tumors, 1958-1987. Radiation Research 137(2): S17-S67, 1994

Supplement: Cancer Incidence in Atomic Bomb Survivors. Radiation Effects Research Foundation, Hiroshima and Nagasaki, Japan || Cancer Incidence in Atomic Bomb Survivors. Part III: Leukemia, Lymphoma and Multiple Myeloma, 1950-1987. Radiation Research 137(2): S68-S97, 1994

Breast cancer incidence among atomic bomb survivors hiroshima and nagasaki 1950 1969. Journal of the National Cancer Institute 59(3): 799-812, 1977

Breast cancer incidence among atomic bomb survivors hiroshima and nagasaki japan 1950 1969. Radiation Research 70(3): 670, 1977

Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1990. Radiation Research 160(6): 707-717, 2003

Incidence of female breast cancer among atomic bomb survivors, Hiroshima and Nagasaki, 1950-1980. Radiation Research 112(2): 243-272, 1987

Incidence of leukemia in survivors of the atomic bomb in Hiroshima and Nagasaki, Japan. American Journal of Medicine 13(3): 311-321, 1952

The incidence of malignant lymphoma and multiple myeloma in Hiroshima and Nagasaki atomic bomb survivors, 1945-1965. Cancer 32(6): 1301-1309, 1973

Studies of the mortality of A-bomb survivors, report 7. Part III. incidence of cancer in 1959-1978, based on the tumor registry, Nagasaki. Radiation Research 93(1): 112-146, 1983

Incidence of coronary heart disease and stroke in atomic bomb survivors living in hiroshima and nagasaki japan 1958 1974. Circulation Suppl. 60(2): II-65, 1979

Incidence of skin cancer among Nagasaki atomic bomb survivors. Journal of Radiation Research 32(Suppl. 2): 217-225, 1991

Incidence of skin cancer among Nagasaki atomic bomb survivors (preliminary report). Journal of Radiation Research 31(3): 280-287, 1990